Dhanapriya Jeyachandran, Dineshkumar Thanigachalam, Sakthirajan Ramanathan, Surendar Dhanikachalam, Gopalakrishnan Natarajan, Balasubramaniyan T
Institute of Nephrology, Madras Medical College and Rajiv Gandhi Government General Hospital, Chennai, Tamil Nadu, India.
Saudi J Kidney Dis Transpl. 2018 Mar-Apr;29(2):452-455. doi: 10.4103/1319-2442.229260.
Paraneoplastic glomerulopathy (PG) includes a group of glomerular lesions that are not directly related to tumor burden, invasion, or metastasis, but induced by products from tumor cells such as hormones, growth factors, cytokines, and tumor antigens. PG was first described by Galloway in 1922, in which nephrotic syndrome (NS) secondary to Hodgkin's lymphoma was reported. They can present before, at the time of diagnosis, during remission, or at relapse of the hematological malignancies. We present three cases of paraneoplastic NS associated with hematological malignancies. Early diagnosis and treatment can alter prognosis of these patients. Paraneoplastic syndromes would remit only with proper treatment of the neoplasia.
副肿瘤性肾小球病(PG)包括一组与肿瘤负荷、侵袭或转移无直接关系,但由肿瘤细胞产生的产物如激素、生长因子、细胞因子和肿瘤抗原所诱发的肾小球病变。PG最早由加洛韦于1922年描述,其中报道了继发于霍奇金淋巴瘤的肾病综合征(NS)。它们可在血液系统恶性肿瘤确诊之前、确诊之时、缓解期或复发时出现。我们报告3例与血液系统恶性肿瘤相关的副肿瘤性NS病例。早期诊断和治疗可改变这些患者的预后。副肿瘤综合征只有在肿瘤得到妥善治疗后才会缓解。